EXOZYMES INC. 8-K

What Happened
eXoZymes Inc. (EXOZ) filed a Form 8-K on March 31, 2026 (Item 8.01) to disclose an updated investor presentation for its NCTx business dated March 30, 2026. The presentation was furnished as Exhibit 99.1 to the filing; the cover page interactive data file (Inline XBRL) was also included.

Key Details

• 8-K filed: March 31, 2026 (Item 8.01 — Other Events).
• Investor presentation dated March 30, 2026 was attached as Exhibit 99.1.
• Interactive cover page (Inline XBRL) submitted as Exhibit 104.
• The filing does not report earnings, executive changes, or other financial statements — it is limited to the updated presentation.

Why It Matters
This 8-K is a company-issued update focused on eXoZymes’ NCTx business delivered via an investor presentation. For retail investors the immediate action is to review the attached presentation to see any new disclosures, timelines, or strategic information the company provided. Because the filing does not include financial results or officer changes, any material financial or management updates would need to appear in subsequent filings or press releases.